NCAM1 and neuroendocrine neoplasm: Taken together, while we could confirm the strong expression of polySia-NCAM on high-grade neuroendocrine neoplasms of the lung, we could not find evidence for a possible use of polySia-NCAM immunohistochemistry as a predictive or prognostic biomarker regarding a response to chemotherapy in these tumors.